Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Journal of the American Academy of Dermatology
|
May 5, 2022
Evaluation of chargemaster price transparency for dermatologic procedures: A national analysis
Kevin Yang, Lara Drake, Shilpa Ghatnekar, et al.
Frontiers in Endocrinology
|
May 18, 2017
Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy
April Ann Cox, Yves Sagot, Gael Hedou, et al.
Experimental Eye Research
|
July 24, 2013
A synthetic connexin 43 mimetic peptide augments corneal wound healing
Keith Moore, Zachary J Bryant, Gautam Ghatnekar, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
February 24, 2015
Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial
Christina L Grek, G M Prasad, Vijay Viswanathan, et al.
Proteomics
|
October 3, 2009
Attovial-based antibody nanoarrays
Peter Ellmark, Sara Ghatnekar-Nilsson, André Meister, et al.
Trends in Biotechnology
|
February 26, 2008
Novel therapies for scar reduction and regenerative healing of skin wounds
J Matthew Rhett, Gautam S Ghatnekar, Joseph A Palatinus, et al.
Coronary Artery Disease
|
July 19, 2013
Bioresorbable polystatin fourth-generation stents
Wayne H Kaesemeyer, Kelly G Sprankle, Jon N Kremsky, et al.
Current Opinion in Pharmacology
|
May 28, 2018
Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics
Christina L Grek, Zhi Sheng, Christian C Naus, et al.
Regenerative Medicine
|
March 26, 2009
Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding
Gautam S Ghatnekar, Michael P O'Quinn, L Jane Jourdan, et al.
BMC Cancer
|
April 17, 2015
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
Christina L Grek, Joshua Matthew Rhett, Jaclynn S Bruce, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Journal of the American Academy of Dermatology
|
May 5, 2022
Evaluation of chargemaster price transparency for dermatologic procedures: A national analysis
Kevin Yang, Lara Drake, Shilpa Ghatnekar, et al.
Frontiers in Endocrinology
|
May 18, 2017
Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy
April Ann Cox, Yves Sagot, Gael Hedou, et al.
Experimental Eye Research
|
July 24, 2013
A synthetic connexin 43 mimetic peptide augments corneal wound healing
Keith Moore, Zachary J Bryant, Gautam Ghatnekar, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|
February 24, 2015
Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial
Christina L Grek, G M Prasad, Vijay Viswanathan, et al.
Proteomics
|
October 3, 2009
Attovial-based antibody nanoarrays
Peter Ellmark, Sara Ghatnekar-Nilsson, André Meister, et al.
Trends in Biotechnology
|
February 26, 2008
Novel therapies for scar reduction and regenerative healing of skin wounds
J Matthew Rhett, Gautam S Ghatnekar, Joseph A Palatinus, et al.
Coronary Artery Disease
|
July 19, 2013
Bioresorbable polystatin fourth-generation stents
Wayne H Kaesemeyer, Kelly G Sprankle, Jon N Kremsky, et al.
Current Opinion in Pharmacology
|
May 28, 2018
Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics
Christina L Grek, Zhi Sheng, Christian C Naus, et al.
Regenerative Medicine
|
March 26, 2009
Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding
Gautam S Ghatnekar, Michael P O'Quinn, L Jane Jourdan, et al.
BMC Cancer
|
April 17, 2015
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
Christina L Grek, Joshua Matthew Rhett, Jaclynn S Bruce, et al.
Page
of 12